How to read HPLC results on peptide COA documentation in Australia when two chromatograms are attached
A peptide certificate of analysis is a compiled experimental record rather than a single chromatogram. In laboratory peptide documentation practice, the HPLC portion is frequently two records bound into one PDF. The purity run is a reversed-phase chromatogram processed by area normalisation: the principal peak area is divided by the sum of integrated peak areas after any documented diluent or void-volume exclusions, and that ratio is reported as chromatographic purity. The related-substances run is a chromatogram, often at a higher on-column load, processed to list individual impurities by relative retention time and area percent, sometimes against named specification rows such as any individual unknown and total related substances.
These attachments are not duplicate print-outs of one data file. They may share column chemistry and a detection wavelength yet differ in stated sample concentration, integration events, acquisition time, and reporting threshold. Reading them as if they were the same chromatogram creates false discrepancies, for example a purity figure of 98.7 percent beside a related-substances table that lists several peaks each between 0.3 and 0.8 percent. Both results can be internally consistent if the related-substances method is intended to bring minor components above the reporting threshold while the purity method is intended to quantify the principal component under non-overloaded detector conditions.
On Australian research-peptide certificates, label each attachment before interpreting any number. Look for distinct method identifiers (RP-HPLC purity versus RP-HPLC related substances), distinct sample-preparation concentrations, and distinct processing-method names in the chromatogram footer. If both traces carry the same data-file name, the same autosampler volume and the same y-axis scale in mAU, they are probably one run printed twice. Suggestions on how to read experimental material in information science emphasise establishing what was measured and under which documented conditions before interpreting a headline percentage (DOI:10.1002/asi.5090180408). Lot-release lines on peptide COA documentation should be traced to a named chromatogram, not treated as free-standing facts.
Which HPLC attachment is the purity run, and which peak table belongs to it?
Identifying the purity run is a document-forensics task. The purity chromatogram typically shows one dominant peak whose area accounts for the large majority of the integrated signal, a y-axis scaled so that the apex sits well below detector saturation (the trace should not be flat-topped), and a peak table with a principal-component row plus few named impurities. The sample-preparation block should state a concentration appropriate to linear ultraviolet response at the documented wavelength, commonly 214 nm for peptides without a strong aromatic chromophore, or 280 nm when aromatic residues are present and that channel is declared.
Read the chromatogram graphic against the peak table, not in isolation. Peak labels, retention times and area percents in the table must match the annotated peaks on the figure. If the figure shows a peak at 12.4 min labelled main and the table lists 12.41 min at 99.1 percent, that is concordance. If the table total of area percents is 100.00 after exclusions, area normalisation has been applied. If a solvent or void peak is visible on the figure but absent from the table, confirm that the processing method documents an exclusion window; undocumented disappearance of a peak is a documentation defect, not a purity improvement.
Footer fields that bind the purity run to the certificate include lot number, sample identifier, method identifier, column description, mobile-phase summary, flow rate, column temperature, detection wavelength, autosampler volume, and processing-method name. Absence of wavelength or processing-method name means the area-percent figure cannot be independently characterised as belonging to that trace. Do not treat peak height percent as purity; height is sensitive to peak width. 13. How to read a journal article stresses matching the claimed result to the methods and to the correct results column; the same matching step applies to a COA peak table (DOI:10.5694/j.1326-5377.1992.tb137249.x). Record which column feeds the summary purity line before filing the pack.
How should a related-substances HPLC chromatogram on a peptide COA be read?
The related-substances chromatogram is read as a list, not as a second purity number. Its purpose is to disclose individual components that the purity-run table may have bundled below a reporting threshold or left unnamed. Expect a higher sample load, a longer acquisition window, a lower ignore limit, and more integrated peaks. The y-axis may look noisier so that peaks near 0.05 to 0.10 percent remain visible. A main peak that is off-scale on this attachment does not automatically invalidate the related-substances table if the method states that the principal component is excluded from the calculation or is reported only as a reference retention time. An undocumented clipped apex should still be flagged if that peak's area were used for purity.
Read the relative retention time column as the identity key for impurities, not the absolute retention time. Absolute retention time shifts with gradient delay, column age and temperature; relative retention time (impurity retention divided by principal-peak retention) is the field that should match the specification table. Named rows such as early-eluting truncation, methionine oxidation, aspartimide or deletion sequences are only as meaningful as the laboratory's identification policy. If names appear without mass-spectrometric confirmation elsewhere in the pack, treat them as chromatographic labels, not structural assignments.
The reporting threshold, sometimes called the ignore limit, determines which peaks enter the table. A certificate that reports total related substances of 1.2 percent with a 0.10 percent ignore limit is not comparable to one that uses 0.05 percent. Record the threshold, the number of peaks reported, the largest individual unknown, and whether a blank chromatogram shows corresponding peaks. Peaks present in the blank at similar relative retention are not sample-related substances. Documentation about Atlas of Living Australia tools is a reminder that needed fields are often distributed across several layers of a documentation system rather than printed on one page (DOI:10.3897/tdwgproceedings.1.19941). If the related-substances method identifier does not appear on the COA summary, the attachment is not bound to the lot result.
What concordance checks bind HPLC results to the lot on an Australian peptide COA?
After each chromatogram is identified, concordance checks test whether the numbers on page one belong to those traces and to the vial in hand. Confirm that the lot number on the COA header, the chromatogram header, the peak table and the vial label are identical. Confirm that the purity percentage on the summary equals the principal-peak area percent on the purity-run table to the stated rounding, for example 98.7 versus 98.72. Confirm that the detection wavelength, column identity and method identifier on the summary match both attachments. The related-substances total plus the principal component will not always sum to 100 percent if different loads and ignore limits were used; the certificate should state that the two methods are not a closed mass balance.
Additional binding fields used in Australian research supply include sample identifier, analyst and reviewer sign-off, report number, acquisition and processing dates, and the data-file name. A chromatogram with a file name that encodes a different lot than the certificate is not evidence for the lot. Sequence tables should show the sample bracketed by blanks and system-suitability standards. The system-suitability chromatogram is a third attachment, not a substitute for the sample purity run.
How (Not) To Read Heidegger is an essay about refusing to import meanings the text does not support (DOI:10.5840/acpq199569241). The same refusal belongs in COA reading: do not infer sequence identity from a single ultraviolet peak, do not infer net peptide content from area-normalised purity, and do not infer that an unnamed bump on the related-substances trace is a specified impurity. Identity typically requires an orthogonal mass-spectrometric result elsewhere in the same pack; chromatographic purity is not molecular-weight confirmation. Local Australian stock, tracked dispatch and batch documentation make these checks practical before material is booked into laboratory inventory.
Which system-suitability and blank fields must be present before HPLC results are accepted as complete?
HPLC results on a peptide COA are not complete if only the sample chromatogram is present. System-suitability documentation shows that the chromatographic system met pre-defined criteria immediately before or during the sequence. Typical fields to read include a retention-time window, repeatability from replicate standard chromatograms, resolution where a pair is declared, a tailing or symmetry factor, and a plate-count or peak-width criterion. Each criterion should have a documented limit and a pass statement. A system-suitability chromatogram without limits is a picture, not a suitability result.
Blank or diluent chromatograms show whether peaks attributed to the sample are present in the system. Read the blank at the same wavelength, the same processing method and a comparable y-axis scale. If the blank is plotted on a compressed scale, minor carry-over can be hidden. Carry-over assessment, where provided, is a subsequent blank after a concentrated sample and belongs with the related-substances run.
A purity result from a chromatogram isolated from system-suitability standards and blanks cannot be characterised as a controlled measurement. Where a sequence table is attached, read vial positions, sample names, and whether the lot identifier matches the certificate. Processing-method version should be identical for sample, system suitability and blank if they are meant to be compared. HOW TO BE READ PIAAC RESULTS FOR ADAPTATION TO NEW AGE? discusses reading tabulated results in context rather than as isolated scores (DOI:10.7816/ulakbilge-05-15-06). HPLC area percents mean nothing without suitability, blank and threshold context.
For evaluation against an Australian catalogue, expect two distinguishable chromatograms, matching lot identifiers, wavelength and method identifiers, system suitability with limits, a blank, and a reporting threshold. Tracked dispatch and batch documentation allow the same pack to be filed against received vials. These checks address whether the analytical record is readable for research-inventory control, not biological effect.
Apply this checklist to documented stock
You now have a practical way to read purity figures, method notes, and lot traceability. When you source materials, hold suppliers to that same checklist — ClaraScience issues batch documentation with every order and dispatches from Australian warehouses with Express tracked shipping.
Start with a retail order to review documentation end-to-end, or register for wholesale if you restock multiple compounds.
Frequently asked questions
Why do some peptide COAs attach two HPLC chromatograms?
One chromatogram is usually the purity run, processed by area normalisation of the principal peak. The second is often a related-substances run at a different load and ignore limit, intended to list individual impurities by relative retention time. They are complementary records, not duplicate prints, and their percentages should not be treated as interchangeable without reading each method identifier.
Should related-substances peak areas plus the main peak equal 100 percent?
Not necessarily. Different sample loads, different ignore limits and different exclusion windows mean the two methods are not a closed mass balance unless the certificate says they are. Concordance means the summary purity matches the purity-run table, and the related-substances table matches its own chromatogram, within stated rounding.
What if the principal peak is flat-topped or off-scale?
On a purity run, a clipped apex undermines area-normalised purity because the area is truncated. On a related-substances run, an off-scale main peak may be acceptable if the method uses that peak only as a retention reference and calculates impurities separately. The method text must say so; otherwise flag the trace as incomplete.
Which fields show that an HPLC attachment belongs to the Australian lot received?
Match lot number across vial label, COA header, chromatogram header and peak table. Match method identifier, detection wavelength and data-file name. Tracked dispatch records should cite the same lot. A chromatogram that lacks these binding fields is not lot evidence for laboratory inventory.
Does HPLC purity on a COA confirm peptide identity?
No. Area-normalised chromatographic purity describes relative peak area under stated conditions. Sequence and molecular-weight identity require orthogonal mass-spectrometric evidence in the same documentation pack. A single ultraviolet peak is not a sequence assignment. Research use only.
What HPLC documentation completeness should be expected before ordering from an Australian catalogue?
Expect distinguishable purity and related-substances chromatograms, system-suitability results with limits, a blank, a reporting threshold, and lot identifiers that match. Local stock and batch documentation support filing the same pack against received vials. Materials remain for laboratory research use only.
References
- DOI:10.1002/asi.5090180408 — Suggestions on how to read experimental material in information science — American Documentation — 1967
- DOI:10.5694/j.1326-5377.1992.tb137249.x — 13. How to read a journal article — Medical Journal of Australia — 1992
- DOI:10.3897/tdwgproceedings.1.19941 — Documentation about Atlas of Living Australia tools: how to find information — Proceedings of TDWG — 2017
- DOI:10.5840/acpq199569241 — How (Not) To Read Heidegger — American Catholic Philosophical Quarterly — 1995
- DOI:10.7816/ulakbilge-05-15-06 — HOW TO BE READ PIAAC RESULTS FOR ADAPTATION TO NEW AGE? — Ulakbilge Dergisi — 2017
Research use only
This article is provided for laboratory research and educational purposes only. Products referenced are not for human or veterinary use. ClaraScience makes no therapeutic, medical, or efficacy claims, and nothing here constitutes medical advice.
